XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 111 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $123,517 | -26.4% | 66,407 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $167,801 | +61.1% | 64,046 | +0.2% | 0.00% | 0.0% |
| Q1 2023 | $104,157 | +25.0% | 63,900 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $83,295 | -15.0% | 62,628 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $98,000 | +3.2% | 62,856 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $95,000 | – | 61,968 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,039,028 | $15,460,000 | 19.22% |
| Stonepine Capital Management, LLC | 7,924,056 | $20,286,000 | 8.41% |
| ARMISTICE CAPITAL, LLC | 7,464,993 | $19,110,000 | 0.37% |
| NEA Management Company, LLC | 3,246,785 | $8,312,000 | 0.24% |
| Alpine Global Management, LLC | 633,040 | $1,620,000 | 0.20% |
| DELTEC ASSET MANAGEMENT LLC | 248,000 | $635,000 | 0.11% |
| Redmile Group, LLC | 1,046,587 | $2,679,000 | 0.08% |
| CTC Capital Management, LLC | 11,800 | $30,000 | 0.08% |
| TUDOR INVESTMENT CORP ET AL | 961,192 | $2,461,000 | 0.06% |
| Yakira Capital Management, Inc. | 117,076 | $300,000 | 0.04% |